Statement on Jury Trial of Ex-CFO of AVEO Pharmaceuticals
Securities and Exchange Commission sent this bulletin at 11/20/2018 05:30 PM EST
You are subscribed to receive no topic from the Securities and Exchange Commission.
This information has recently been updated, and is now available.
11/20/2018 12:03 PM EST
Statement from SEC Enforcement Division Co-Directors on outcome of jury trial of former AVEO Pharmaceuticals CFO.
You can update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time to SEC news on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com. For more information on collecting personally identifiable information, please read the SEC’s privacy policy.
Follow the SEC on Twitter:
